Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer

Anticancer Research

Volumn 17, Issue 5 B, 1997, Pages 3761-3765

  Recchia, Francesco ^a,c,f   Sica, Gigliola ^b   De Filippis, Sandro ^a   Rea, Silvio ^c,d   Frati, Luigi ^c,e  

^a Civilian Hospital   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c CROFI Monterotondo   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f NONE   (Italy)

Author keywords

Beta interferon; Chemotherapy; Non small cell lung cancer; Retinyl palmitate

Indexed keywords

BETA INTERFERON; CISPLATIN; FLUOROURACIL; RETINOL PALMITATE; VINDESINE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HISTOLOGY; HUMAN; HYPERTRIGLYCERIDEMIA; ILEUS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY INJURY; LEUKOPENIA; LIVER DISEASE; LUNG NON SMALL CELL CANCER; MALE; NERVOUS SYSTEM INJURY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN TOXICITY; STOMATITIS; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

AGED; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INTERFERON-BETA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; SURVIVAL RATE; VINDESINE; VITAMIN A;

EID: 0031441115     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Stanley K and Stjernswald J: Lung cancer: A worldwide health problem. Chest (Suppl) 96: 1-5, 1989.
2. Rapp E, Pater JL, Willian A, Cormier Y, Murray N, Evans WK, Hodson DI, Clark DA, Feld R, Arnold AM, Ayoub JI, Wilson KS, Latreille J, Wierzbicky RF and Hill DP: Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: Report of a Canadian multicenter randomised trial. J Clin Oncol 6: 633-641, 1988.
3. Gralla RJ, Casper ES, Kelsen DP, Brown DW Jr, Dukeman ME, Martini N, Young CW and Golden RB: Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomised trial investigating two dosage schedules. Ann Intern Med 95: 414-420, 1981.
4. Farber LP, Kittle CF, Warren WH, Bonomi PD, Taylor SG, Reddy S and Lee MS: Preoperative chemotherapy and irradiation for stage III non-small-cell lung cancer. Ann Thorac Surg 47(5): 669-675, 1989.
5. Srikland S and Mahdavi V: The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15: 393-403, 1980.
6. Breitman TR, Selonick SE and Collins SJ: Terminal differentiation of promyelocytic leukemia cells in primary culture in response to retinoic acid. Blood 57: 1000-1004, 1981.
7. Lotan R: Effect of vitamin A and its analogues (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605: 33-91, 1980.
8. Sporn MB and Roberts AB: Role of retinoids in differentiation and carcinogenesis. Cancer Res 43: 3034-3040, 1983.
9. Lippman SM, Kessler JF and Meyskens FL Jr: Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat Rep 71: 493-515, 1987.
10. Huang ME, Ye YC, Chen SR, Zhan JC, Gu LJ Zhao L, Zie JX, Shen ZX and Wang ZX: Use of all trans-retinoic acid in the treatment of acute promyelocytic leukemia. Clinical results. Blood 76: 567-572, 1988.
11. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW and Goepfert H: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. New Engl J Med 323: 795-801, 1990.
12. Borden EC, Hogan TF and Voelkel JG: Comparative antiproliferative activity in vitro of natural interferon alpha and beta for diploid and transformed human cells. Cancer Res 42: 4989-4993, 1982.
13. Ettinger DS and Harwood K: Phase II Study of beta interferon in patients with advanced non-small-cell lung cancer. Med Pediatr Oncol 16: 30-32, 1988.
14. Marth C, Daxenbichler G and Dapunt O: Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells. J Natl Cancer I 77: 1187-1202, 1986.
15. Spear GT, Paulnock DM, Jordan RL, Meltzer DM, Merritt JA and Borden EC: Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta interferon. Clin Exp Immunol 69: 107-115, 1987.
16. Prabhala RH, Garewal HS, Hicks MJ, Sampliner RE and Watson RR: The effect of 13-cis-retinoic acid and beta-carotene on cellular immunity in humans. Cancer 67: 1556-1560, 1991.
17. Bendich A and Langseth L: Safety of vitamin A. Am J Clin Nutr 49: 358-371, 1989.
18. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
19. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Fiket P, Rosmentz N, Clerici M, Soresi E, Valente M, Belloni PA and Ravasi G: Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 11: 1216-1222, 1993.
20. Rinaldi DA, Lippman SM, Burris HA, Chou C, Hoff DD and Hong WK: Phase II study of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced squamous cell lung cancer. Anti-Cancer Drug 4: 33-36, 1993.
21. Arnold A, Ayoub J, Douglas L, Hoogedorn P, Skingley L, Gelmon K, Hirsh V and Heisenhauer E: Phase II trial of 13-cis-retinoic acid plus interferon in non-small-cell lung cancer. J Natl Cancer I 86: 306-309, 1994.
22. Athanasiadis I, Kies MS, Miller M, Ganzenko N, Joob A, Marymont MA, Rademaker A and Gradishar WJ: Phase II study of all-trans-retinoic acid and α-interferon in patients with advanced non-small cell lung cancer. Clin Cancer Res 1: 973-979, 1995.
23. Mandanas R, Einhorn LH, Wheeler B, Ansari R, Lutz T and Miller ME: Carboplatin (CBDCA) plus alpha interferon in metastatic non-small-cell lung cancer. Am J Clin Oncol 16: 519-521, 1993.
24. Rosell R, Carles J, Ariza A, Moreno I, Ribelles N, Solani V, Pellicer I, Barnadas A and Abad A: A phase II study of days 1 and 8 cisplatin and recombinant alpha-2b interferon in advanced non-small-cell lung cancer. Cancer 67: 2448-2453, 1991.
25. Halme M, Maasilta PK, Pyohnen SO and Mattson KV: Interferons combined with chemotherapy in the treatment of non-small-cell lung cancer. A randomised study. Eur J Cancer 30A: 11-15, 1994.
26. Lama G, Angelucci C, Recchia F and Sica G: Effect of 13-cis-retinoic acid, tamoxifen and interferon on the growth of human breast cancer cells. Cancer Lett 100: 181-189, 1996.
27. Nair S, Mayotte J, Lokshin A and Levitt M: Induction of squamous differentiation by interferon ß in a human non-small-cell lung cancer cell line.J Natl Cancer I 86: 378-383, 1994.
28. Lotan R, XU X-C, Lippman SM, Ro JY, Lee JS, Lee JJ and Hong WK: Suppression of retinoic acid recptor-ß in premalignant oral lesions and its up-regulation by isotretinoin. New Engl J Med 332: 1405-1410, 1995.